Maryland Heights, MO, January 20, 2017 --(PR.com
)-- The global cancer diagnostics market is estimated to reach USD 153 Billion in 2020, expanding at a CAGR of 7.2% from 2016 to 2020. By diagnostic method, cancer diagnostic imaging segment, specially endoscopy sub-segment and by application lung cancer detection contributed the largest share of global market. The same growth trends are likely to continue during the forecast period from 2016-2020. The rising prevalence of cancer across the globe is driving the global cancer diagnostics market, whereas higher incidences of cancer and increasing healthcare spending is expected to aid the global tissue diagnostics market.
Cancer diagnostic testing involves tests and procedures to confirm the presence of disease and identify the correct tumor type, location, extent and stage. The most common diagnostic tests include biopsy tests (bone marrow, endoscopic, needle biopsy), endoscopy tests (bronchoscopy, colonoscopy, colposcopy, sigmoidoscopy, etc.), diagnostic imaging (CT, MRI, PET, mammography, ultrasound, etc.), and detection of cancer-specific tumor biomarkers.
Browse Cancer Diagnostics Market by Diagnostic Method such as Biopsy Test (Bone Marrow, Endoscopic, Needle Biopsy), Endoscopy Test (Bronchoscopy, Colonoscopy, Colposcopy, Sigmoidoscopy), Diagnostic Imaging (CT, MRI, PET, Mammography, Ultrasound), and Detection of Cancer-Specific Tumor Biomarkers, and by Application (Organ or Cell-Specific Cancer Types such as Blood, Breast, Colorectal, Kidney, Liver, Lung, Ovarian, Pancreatic, Prostate Cancer) 2016-2020 at https://www.ihealthcareanalyst.com/report/cancer-diagnostics-market/.
The global cancer diagnostics market report estimates the market size (Revenue USD million - 2013 to 2020) for market segmentation based on testing methods and their applications (organ or cell-specific cancer types – blood, breast, colorectal, kidney, liver, lung, ovarian, pancreatic, and prostate cancer) and forecasts growth trends (CAGR% - 2016 to 2020). The global cancer diagnostics market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
The global cancer diagnostics market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments.
Major players operating in the global cancer diagnostics market and included in this report are Abbott Laboratories, Ambry Genetics, AstraZeneca, bioMerieux, Genentech, Genoptix (Novartis), and Roche Diagnostics.
To request Table of Contents and Sample Pages of this report visit: https://www.ihealthcareanalyst.com/report/cancer-diagnostics-market/
iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.
In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.
2109, Mckelvey Hill Drive
Maryland Heights, MO 63043